3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Hodgkin Disease
1
Interventions
Peripheral Blood Stem Cell Transplantation
39
fludarabine phosphate
36
Cyclophosphamide
31
Mycophenolic Acid
28
Cyclosporine
25
Whole-Body Irradiation
24
Tacrolimus
22
Busulfan
18
Antilymphocyte Serum
18
Radiotherapy
16
Methotrexate
16
Flow Cytometry
14
Filgrastim
14
Etoposide
13
Methylprednisolone
10
Lenalidomide
10
Bortezomib
10
Vorinostat
9
Melphalan
9
mogamulizumab
8
Therapeutics
8
Rituximab
8
Psychiatric Rehabilitation
8
Polymerase Chain Reaction
8
Gemcitabine
8
Cord Blood Stem Cell Transplantation
7
Bexarotene
7
pembrolizumab
6
Alemtuzumab
6
tanespimycin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
resminostat
×
Lymphoid
×
Clear all
NCT02953301
2024-08-30
RESMAIN
4SC AG
Phase 2
Completed
201 enrolled